Research Articles

March 22, 2021

IVIG Shows Promise for Treating Pediatric Acute-Onset Neuropsychiatric Syndrome

Extended Dosing Provided Sustained Benefits up to 46 Weeks After Final Infusion Children who present with sudden and severe neuropsychiatric behaviors such as obsessive compulsive disorder (OCD), eating disorders, tics, anxiety, irritability, and problems with attention and focus are typically diagnosed with either pediatric acute-onset neuropsychiatric syndrome (PANS) or pediatric autoimmune neuropsychiatric disorders associated with […]

March 22, 2021

Assisted Autistic Communication Does Not Warrant Blanket Dismissal by Critics

Eye-Tracking Study Proves Genuine Communication Generated by Participant  A recent study affiliated with the University of Virginia has examined the authenticity of a controversial communication practice for non-verbal individuals on the spectrum called facilitated communication or assisted autistic communication.  For years, this method has come under scrutiny due its reliance upon the assistance of another […]


March 08, 2021

Mood Disorders Are Significantly More Common in ASD

And Challenging to Diagnose Due to Atypical Presentation  A recent British review article published in the International Review of Psychiatry presented a thorough investigation into the occurrence of higher rates of mood disorders in individuals with autism than in the general population. The most common mood disorders include major depressive disorder, bipolar disorder and seasonal […]

March 01, 2021

How Gut Microbes and Brain Disorders Could Be Linked

Findings May Lead to Microbiome Drugs for Neurodegenerative and Neuropsychiatric Disorders Fifteen years ago, neuroscientist Jane Foster discovered that bacteria in the gut may have influence over brain function and behavior. She came to this conclusion by conducting studies using two groups of mice. One group had healthy gut microbes and the other group lacked […]

March 01, 2021

Further Details Show Psilocybin to be a Budding New Autism Treatment

The Psychedelic Substance Supports Microbiome and Normalizes Serotonin Levels Last month, SafeMinds Shares reported on the stir psilocybin was creating in the financial world.  Market analysts and investors were viewing the psychedelic as a potential revolutionary autism treatment.  The autism treatment market is currently valued at $3.2 billion and is desperately lacking in drug therapies. […]

Show Buttons
Hide Buttons